RE104 for adjustment disorder related to cancer or other serious illnesses
Part of Brain & nervous system, Cancer, Hormones & metabolism, Immune system & allergy, Lungs & breathing, Mental health clinical trials.
This trial is testing a new medication (RE104) for people who have adjustment disorder with depressed mood or anxiety because of a serious medical condition like cancer, ALS, MS, Parkinson's, or lung fibrosis. It's a study to see if the drug is safe and reduces symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with adjustment disorder due to a serious medical illness (such as cancer, ALS, MS, Parkinson's, or IPF)
- Able to take care of yourself and walk around (no bed rest needed)
- No history of bipolar, schizophrenia, or other psychotic disorders
- No current suicidal risk or recent suicidal behavior
- Not pregnant or planning to become pregnant (or partner become pregnant) during the trial
- Willing to stay on your current antidepressants or therapy, or pause new ones until the study ends
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether psilocybin (a psychedelic drug given with talk therapy) can help people with cancer who have adjustment disorder—a condition where a cancer diagnosis causes severe anxiety or stress. It focuses on reducing anxiety and improving emotional well-being.
This trial tests a new medication called RE104 for people with generalized anxiety disorder (GAD). The goal is to see if it helps reduce anxiety symptoms safely.
This trial tests a new medicine called ACP-211 in adults with major depression who have not gotten enough relief from at least two previous antidepressants. The goal is to see if it can help when other treatments have not worked well.
This trial tests a new medication called ABX-002 as an add-on to your current antidepressant. It's for people with moderate to severe depression who haven't gotten enough help from their current antidepressant alone.
This trial tests an investigational pill (PDC-1421) to see if it can safely and effectively treat depression in people with cancer. If you're struggling with mood during cancer treatment, this study might offer a new option.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
Hear when a new Adjustment Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.